Skip to content

Effects of mindfulness Meditation (MBSR) on daytime sleepiness for excessive daytime sleepiness: A randomized controlled pilotstudy

Effects of mindfulness Meditation (MBSR) on daytime sleepiness for excessive daytime sleepiness: A randomized controlled pilotstudy - mind_EDS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026812
Enrollment
20
Registered
2021-10-13
Start date
2021-09-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.3

Interventions

Group 1: Mindfulness-Based Stress reduction (MBSR) standardized program following Kabat-Zinn: 8 weeks with weekly group meetings and daily individual exercises Group 2: stress management, learning str
8 weeks with weekly group sessions and daily exercises

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: - ESS score > 10 - diagnosis of obstructive sleep apnea - ongoing PAP-therapy which was started at least a month ago or previous attempt of a PAP-therapy - no start of a further therapy of sleep apnea during the course of the study - no very extensive previous meditation experience - no very extensive previous experience with formal exercises for stress management or acceptance- and commitment therapy - written consent

Exclusion criteria

Exclusion criteria: - acute major depressive disorder or suicidality - acute or chronic condition requiring treatment which presumably does not allow full participation in either of the programs - drug or alcohol dependency - insufficient knowledge of the German language

Design outcomes

Primary

MeasureTime frame
daytime sleepiness, before and after the intervention, via questionnaire (Epworth Sleepiness Scale)

Secondary

MeasureTime frame
quality of life, health-related quality of life, sleep quality, sleep latency, total sleep time, sleep efficiency, sleep disturbance, stress, anxiety, depressive symptoms; via questionnaire, before and after the intervention

Countries

Germany

Contacts

Public ContactMax Hellrigel-Holderbaum

Charité Campus Charité Mitte

max.hellrigel-holderbaum@charite.de030 450 513 123

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026